Abdul Mundia
Hematology & Oncology · Rockville Centre, NYNPI 1669672101
Payments from drug & device makers
Across 185 payments — averaging $118.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$6K
- Beigene USA, Inc.$3K
- Incyte Corporation$3K
- Athenex Pharmaceutical Division, LLC$3K
- AstraZeneca$1K
- Daiichi Sankyo Inc.$1K
- plus $5K from 31 others
What the payments were for
- Consulting fees$12,54657%
- Speaking & faculty fees$3,95018%
- Travel & lodging$1,8588%
- Food & beverage$3,19215%
- Education$3332%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 14 | $5,891 |
| Beigene USA, Inc. | 4 | $3,358 |
| Incyte Corporation | 22 | $2,836 |
| Athenex Pharmaceutical Division, LLC | 6 | $2,522 |
| AstraZeneca(2 entities) | 4 | $1,439 |
| Daiichi Sankyo Inc. | 5 | $1,266 |
| Sanofi | 11 | $1,049 |
| Gilead | 1 | $530 |
| Pfizer | 22 | $438 |
| Johnson & Johnson | 13 | $365 |
| Cardinal Health 110 LLC | 1 | $275 |
| Vertex | 1 | $258 |
| Puma Biotechnology, Inc. | 10 | $238 |
| E.r. Squibb & Sons, L.L.C. | 11 | $201 |
| Novartis | 9 | $160 |
| GSK | 2 | $129 |
| Merck | 7 | $122 |
| Lilly USA, LLC | 5 | $103 |
| Bristol Myers Squibb | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Karyopharm Therapeutics Inc. | 3 | $62 |
| Amgen | 3 | $58 |
| Global Blood Therapeutics, Inc. | 3 | $56 |
| Dova Pharmaceuticals | 3 | $52 |
| Array Biopharma Inc | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Tersera Therapeutics LLC | 1 | $26 |
| Taiho Oncology, Inc. | 2 | $25 |
| Acrotech Biopharma Inc. | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $23 |
| AbbVie | 1 | $20 |
| Verastem, Inc. | 1 | $20 |
| Seagen Inc. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nexavar$5,588
- BRUKINSA$3,358
- Oral Paclitaxel$2,500
- Encequidar$2,500
- MONJUVI$2,320
- VANFLYTa$650
- ALPROLIX$475
- ELOCTATE$475
- CABLIVI$400
How this compares
$21,879 in reported general payments places this provider in the 65th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in Rockville Centre
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Richard ZunigaBabylon$10.9M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.